acut
lower
respiratori
tract
infect
result
bronchiol
remain
among
common
caus
hospit
admiss
develop
world
children
younger
age
year
younger
year
bronchiol
caus
respiratori
syncyti
viru
rsv
primari
caus
older
year
infect
rhinoviru
rv
promin
rsv
bronchiol
associ
increas
subsequ
wheez
ill
long
consid
associ
may
play
caus
role
develop
asthma
research
shown
sever
earlylif
infect
rsv
associ
increas
risk
infrequ
wheez
odd
ratio
confid
interv
ci
p
frequent
wheez
p
age
year
longer
associ
episod
wheez
age
year
also
associ
rsv
lower
respiratori
tract
ill
develop
allerg
diseas
though
rsv
lower
respiratori
tract
ill
associ
significantli
lower
lung
function
age
year
support
observ
lu
et
al
also
went
show
risk
asthma
diagnosi
age
year
determin
sever
acut
rsv
episod
along
famili
histori
asthma
highlight
interact
atopi
similarli
sever
rsv
bronchiol
result
hospit
associ
sixto
eightfold
increas
admiss
wheez
first
month
rsv
hospit
longer
increas
year
later
howev
diagnosi
asthma
risk
hospit
rsv
infect
increas
threefold
risk
time
depend
suggest
host
factor
associ
diagnosi
asthma
age
increas
suscept
rsv
effect
rsv
alon
airway
symptom
wheez
transitori
rv
infect
second
common
viru
associ
bronchiol
common
viru
detect
associ
wheez
ill
children
age
year
three
speci
rv
human
rv
hrv
hrvb
asthma
virus
bronchiol
respiratori
syncyti
viru
rhinoviru
airway
microbiota
genet
suscept
abstract
asthma
remain
preval
chronic
respiratori
disord
affect
peopl
age
relationship
respiratori
viru
infect
asthma
long
recogn
though
remain
incomplet
understood
articl
address
key
issu
around
relationship
includ
crucial
role
viru
infect
play
earli
life
potenti
risk
factor
develop
asthma
lung
diseas
assess
impact
viru
infect
establish
asthma
trigger
acut
diseas
may
influenc
asthma
throughout
life
final
explor
complex
interact
occur
airway
immun
respons
make
asthma
suscept
effect
viru
infect
hrvc
recogn
includ
antigen
distinct
viru
subtyp
like
also
repres
serotyp
explain
lifelong
suscept
rv
infect
differ
associ
rv
speci
diseas
observ
rva
recent
discov
rvc
respons
sever
lower
respiratori
tract
ill
hrva
hrvb
grown
standard
laboratori
cell
line
enabl
isol
clinic
sampl
classif
accord
neutral
antibodi
respons
serotyp
occur
led
identif
approxim
strain
hrvc
discov
could
cultur
use
standard
techniqu
henc
gone
unappreci
pathogen
hrvc
shown
infect
youngest
children
caus
sever
acut
rvinduc
lower
respiratori
tract
diseas
research
abl
cultur
hrvc
use
respiratori
mucos
explant
airliquid
interfac
differenti
bronchial
epithelium
determin
use
human
transmembran
protein
cadherinrel
famili
member
viru
bind
replic
serendipit
recent
shown
four
distinct
allel
associ
express
one
repres
singl
nucleotid
polymorph
g
convert
residu
cystein
tyrosin
posit
cy
tyr
lead
rare
phenotyp
domin
asthmarel
aencod
variant
gene
link
greater
airway
epitheli
cell
aec
surfac
express
increas
risk
wheez
ill
hospit
children
year
bochkov
et
al
went
show
compar
wildtyp
cell
transfect
asthma
suscept
variant
increas
hrvc
bind
increas
infecti
viru
yield
find
first
link
genet
suscept
respiratori
tract
infect
develop
childhood
asthma
allerg
sensit
also
intertwin
risk
develop
asthma
virusinduc
wheez
children
develop
sensit
multipl
aeroallergen
younger
age
prone
develop
sever
acut
asthma
need
hospit
relationship
viru
infect
allerg
sensit
elegantli
demonstr
investig
childhood
origin
asthma
studi
coast
studi
show
children
sensit
aeroallergen
wheez
rv
first
year
life
greatest
risk
develop
asthma
investig
went
demonstr
sequenti
relationship
allerg
sensit
lead
viral
wheez
especi
wheez
associ
rv
evid
viral
wheez
led
allerg
sensit
fact
impact
rv
infect
earli
life
subject
metaanalysi
origin
studi
report
result
longitudin
cohort
studi
differ
followup
period
rv
wheez
ill
first
year
life
associ
increas
risk
wheezingasthma
later
life
rel
risk
rr
ci
p
subgroup
analysi
done
age
followup
associ
signific
year
rr
ci
p
year
rr
ci
p
therefor
seen
rsv
host
suscept
link
atopi
demonstr
famili
histori
allerg
asthma
confer
signific
risk
rvinduc
wheez
impact
viral
infect
earli
life
role
play
incept
asthma
best
summar
gern
buss
state
sever
infect
stage
result
nonexclus
outcom
first
may
impair
normal
lung
develop
second
may
trigger
wheez
ill
suscept
individu
given
close
associ
viral
bronchiol
childhood
asthma
intervent
prevent
least
reduc
sever
diseas
potenti
could
import
longlast
effect
although
possibl
rv
infect
develop
human
monoclon
antibodi
target
rsv
f
protein
palivizumab
allow
passiv
immun
reduc
suscept
sever
rsv
bronchiol
preterm
highrisk
infant
reason
investig
random
otherwis
healthi
preterm
infant
treatment
palivizumab
placebo
treat
infant
ci
rel
reduct
total
number
wheez
day
first
year
life
proport
infant
recurr
wheez
point
lower
treat
palivizumab
vs
p
similarli
size
studi
look
outcom
year
age
follow
palivizumab
treatment
first
year
life
fewer
record
episod
wheez
differ
seen
doctor
diagnosi
asthma
interest
determin
whether
intervent
impact
either
lung
function
asthma
later
age
interact
develop
immun
system
viral
infect
earli
life
also
occur
backdrop
exposur
bacteria
airway
microbiota
recent
healthi
lower
airway
consid
harbor
bacteria
understand
respiratori
microbiota
chang
advent
cultureindepend
techniqu
involv
highthroughput
sequenc
rrna
gene
highli
conserv
locu
bacteri
genom
reveal
complex
microbi
commun
vari
state
health
respiratori
diseas
relationship
bacteri
colon
earlylif
asthma
first
demonstr
copenhagen
birth
cohort
show
heighten
risk
wheez
asthma
children
whose
nasopharynx
colon
streptococcu
pneumonia
moraxella
catarrhali
haemophilu
influenza
month
age
bacteria
also
present
acut
episod
wheez
associ
viral
infect
confer
similar
degre
risk
acut
wheez
teo
et
al
collect
nasopharyng
aspir
children
month
age
within
hour
clinic
respiratori
tract
infect
appli
modern
method
rrna
gene
sequenc
went
assess
chang
upper
airway
microbiota
chronic
wheez
age
year
staphylococcu
corynebacterium
organ
known
part
skin
microbiom
domin
speci
first
month
life
chang
alloiococcu
moraxella
month
concomit
stabil
microbi
popul
specul
infant
like
colon
initi
skin
bacteria
parent
popul
replac
time
moraxella
alloiococcu
upper
respiratori
microbiota
remain
stabl
time
healthi
individu
howev
infant
viru
respiratori
infect
greater
abund
streptococcu
moraxella
haemophilu
earli
moraxella
colon
associ
younger
age
first
viral
upper
respiratori
infect
streptococcu
colon
associ
earlier
initi
lower
respiratori
infect
level
subsequ
asthma
risk
found
invers
relat
age
initi
streptococcu
colon
occur
investig
specul
lower
airway
infect
rsv
rv
contribut
alter
microb
featur
streptococcu
result
effect
airway
andor
develop
immun
system
predispos
develop
asthma
intrigu
area
obvious
requir
work
fascin
see
exposur
earli
life
pathogen
either
viral
bacteri
alter
airway
immun
respons
profoundli
hygien
hypothesi
develop
explain
relationship
microbi
exposur
earli
life
protect
allerg
autoimmun
diseas
continu
increas
preval
particularli
western
societi
propos
improv
hous
chang
urban
lifestyl
may
respons
lack
exposur
bacteri
pathogen
earli
life
result
immun
respons
becom
skew
develop
hypersensit
allergi
apart
infect
exposur
multipl
bacteri
antigen
occur
indoor
outdoor
environ
bacteri
product
lipopolysaccharid
lp
endotoxin
recogn
foreign
innat
immun
system
exposur
especi
earli
life
activ
develop
immun
system
support
concept
highlevel
chronic
exposur
lp
shown
experiment
induc
immun
toler
hypothesi
support
german
investig
examin
sampl
dust
mattress
children
relat
level
endotoxin
preval
asthma
allergi
serum
level
specif
immunoglobulin
e
ige
found
children
expos
farm
dust
contain
high
level
lp
associ
signific
decreas
risk
hay
fever
atop
sensit
atop
asthma
atop
wheez
childhood
work
support
strong
epidemiolog
studi
confirm
earlylif
exposur
farm
bacteri
lp
significantli
reduc
risk
asthma
recent
mechan
behind
regul
start
understood
aec
regul
protein
play
key
role
deubiquitinas
essenti
neg
regul
nuclear
activ
subsequ
induct
inflammatori
respons
form
uniqu
ubiquitinedit
complex
protein
requir
activ
knockout
mice
highli
suscept
exposur
inflammatori
mediat
lp
recent
import
role
emerg
regul
earli
asthma
mice
expos
low
level
lp
earli
life
develop
featur
asthma
despit
sensit
hous
dust
mite
hdm
use
knockout
mice
select
defici
aec
protect
effect
lp
diminish
increas
epitheli
express
inflammatori
mediat
chemokin
cc
motif
ligand
ccl
granulocyt
macrophag
colonystimul
factor
gmcsf
follow
hdm
human
aec
lp
treatment
also
blunt
inflammatori
respons
gmcsf
interleukin
il
follow
hdm
exposur
bring
find
togeth
schuij
et
al
demonstr
lpsexpos
epitheli
cell
cytokin
respons
activ
dendrit
cell
dc
suppress
type
immun
hdm
loss
ubiquitinmodifi
enzym
lung
epithelium
abolish
protect
effect
also
demonstr
singlenucleotid
polymorph
gene
encod
associ
allergi
asthma
risk
children
grow
farm
prevent
exposur
rsv
may
risk
earlylif
asthma
exposur
bacteri
polyprotein
may
convers
protect
preliminari
evid
hint
recent
studi
perform
use
extract
bacteri
product
bv
safe
given
oral
prepar
preliminari
studi
suggest
children
treat
bv
demonstr
immun
respons
skew
away
type
immun
increas
interferon
ifn
ratio
small
clinic
trial
also
shown
use
decreas
asthma
exacerb
year
old
attack
reduc
day
shorter
bv
versu
placebo
p
fact
bv
reduc
attack
greater
degre
inhal
corticosteroid
viral
infect
highli
link
wheez
earli
life
subsequ
develop
asthma
associ
viral
infect
exacerb
asthma
adolesc
adult
establish
diagnosi
asthma
particularli
strong
current
global
initi
asthma
gina
describ
exacerb
acut
chang
symptom
lung
function
typic
requir
chang
manag
though
consensu
defin
exacerb
poor
acut
exacerb
lead
caus
asthma
death
hospit
estim
cost
associ
treatment
asthma
due
exacerb
despit
happen
minor
patient
given
graviti
associ
asthma
exacerb
much
work
etiolog
acut
event
identifi
viral
infect
respons
major
asthma
exacerb
children
adult
thu
discuss
role
virus
epidemiolog
risk
factor
exacerb
influenc
asthma
control
gener
infect
respiratori
virus
remain
common
caus
upper
respiratori
tract
infect
urti
infect
rv
common
repres
document
case
follow
infect
coronaviru
parainfluenza
influenza
rsv
enteroviru
adenoviru
major
virus
tend
involv
aec
infect
upper
respiratori
tract
subsequ
inflamm
influenza
rsv
distinguish
propens
infect
lower
respiratori
tract
caus
particularli
sever
damag
airway
epitheli
layer
lead
increas
diseas
sever
rv
common
caus
urti
common
viral
infect
man
also
common
viru
associ
exacerb
asthma
inde
upward
acut
exacerb
asthma
link
viru
infect
due
rv
repres
higher
proport
patient
affect
rv
found
gener
popul
associ
urti
led
insight
patient
asthma
may
actual
suscept
viral
infect
observ
patient
asthma
like
develop
sever
lower
respiratori
tract
symptom
set
viral
infect
healthi
individu
uniformli
associ
rv
heterogen
associ
respons
rv
infect
among
strain
identifi
particular
note
lower
respiratori
tract
infect
rv
occur
day
initi
symptom
begin
correl
well
time
asthma
exacerb
rvinduc
asthma
exacerb
tend
occur
autumn
spring
mirror
increas
incid
infect
gener
popul
rsv
influenza
make
remain
viralinduc
asthma
exacerb
previous
note
rsv
particularli
import
pathogen
children
younger
year
age
winter
past
thought
less
common
adult
acut
exacerb
asthma
howev
widespread
test
adult
hospit
set
becom
increasingli
recogn
seriou
common
caus
lower
respiratori
tract
infect
especi
elderli
influenza
commonli
caus
asthma
exacerb
winter
month
also
preval
asthma
set
influenza
infect
associ
wors
diseas
sever
higher
risk
hospit
need
intens
care
mortal
although
implic
small
proport
asthma
exacerb
adenoviru
similarli
link
sever
diseas
asthma
heterogen
diseas
airway
inflamm
airway
hyperrespons
ahr
multidimension
natur
mean
look
diseas
mani
angl
assess
individu
respond
particular
insult
especi
true
differ
respons
viral
infect
patient
asthma
healthi
patient
gener
compar
healthi
individu
without
asthma
corn
et
al
show
commun
cohort
studi
patient
asthma
suscept
get
rv
infect
healthi
individu
much
prone
develop
lower
respiratori
tract
involv
sever
symptom
differ
immun
respons
asthma
may
account
may
complex
interact
inflamm
seen
asthma
abil
respond
viru
infect
airway
risk
factor
usual
distinguish
patient
asthma
asthmat
demonstr
defici
immun
respons
viral
infect
vitro
experi
rv
shown
patient
asthma
higher
level
viral
replic
follow
infect
control
subject
inde
experiment
studi
impli
defici
ifnmedi
antivir
respons
patient
asthma
contributori
process
though
find
alway
observ
particularli
mild
diseas
natur
studi
limit
number
find
clinic
asthma
strongli
suggest
risk
acut
asthma
vari
could
restrict
certain
risk
acut
asthma
phenotyp
concept
support
find
defici
type
ifn
respons
found
sever
asthma
recent
hypothesi
correct
defici
airway
antivir
respons
would
improv
outcom
acut
asthma
test
random
asthmat
receiv
nebul
develop
cold
symptom
subject
moderatetosever
asthma
histori
cold
induc
acut
asthma
subject
develop
cold
major
develop
acut
asthma
treatment
nebul
overal
result
signific
improv
howev
poor
control
despit
treatment
cold
symptom
led
greater
worsen
asthma
nebul
led
signific
attenu
may
partli
explain
alter
immun
system
due
activ
inflamm
sinc
atop
children
shown
particularli
risk
sever
viral
exacerb
mitig
antiig
therapi
risk
factor
requir
explor
includ
low
vitamin
level
higher
level
stress
suspect
play
part
reduc
immun
viral
infect
contribut
risk
exacerb
result
higher
level
viral
replic
insuffici
ifn
product
associ
airway
inflamm
occur
concurr
could
certainli
explain
propens
frequent
exacerb
import
acut
asthma
increasingli
acknowledg
intern
guidelin
seek
minim
risk
clinic
factor
associ
increas
risk
acut
asthma
poor
asthma
symptom
control
sever
asthma
defin
gina
base
lower
forc
expiratori
volum
second
fev
smoke
exacerb
frequenc
also
link
poor
asthma
control
appear
complex
relationship
poor
asthma
control
suscept
viru
infect
major
research
asthma
exacerb
includ
wellcontrol
individu
jackson
et
al
demonstr
uncontrol
asthmat
experi
frequent
lower
respiratori
tract
symptom
wors
fall
fev
slower
recoveri
compar
wellcontrol
individu
exacerb
independ
asthma
sever
bateman
et
al
shown
clear
link
asthma
control
predict
futur
risk
exacerb
far
abl
demonstr
improv
exacerb
rate
better
control
kupczyk
et
al
shown
cohort
patient
sever
asthma
frequent
exacerb
correl
marker
ongo
inflamm
exhal
nitric
oxid
higher
sputum
eosinophil
also
shown
asthmat
moderatetosever
diseas
persist
eosinophil
inflamm
show
reduc
tolllik
receptor
tlr
express
along
impair
ifn
express
endobronchi
biopsi
support
concept
poor
asthma
control
along
persist
asthmat
inflamm
respons
increas
suscept
viru
infect
investig
demonstr
cohort
children
high
risk
acut
exacerb
asthma
addit
omalizumab
monoclon
antibodi
ige
ad
regimen
guidelinesbas
therapi
improv
asthma
control
nearli
elimin
season
peak
exacerb
previous
shown
associ
viru
infect
also
went
show
subgroup
treatment
omalizumab
improv
vitro
ifn
respons
rv
demonstr
greatest
improv
greatest
reduct
exacerb
frequenc
histori
smoke
identifi
risk
factor
frequent
exacerb
inde
vitro
work
confirm
cigarett
smoke
exposur
associ
impair
ifn
product
suggest
plausibl
method
higher
exacerb
frequenc
due
impair
antivir
respons
thu
predict
exacerb
passiv
exposur
cigarett
smoke
also
link
risk
exacerb
children
extend
pollut
environ
gener
exposur
pollut
sulfur
nitrogen
dioxid
also
risk
factor
viral
exacerb
asthma
wellcontrol
asthma
defin
current
gina
guidelin
caus
infrequ
symptom
need
reliev
therapi
limit
exercis
toler
optim
adher
psychosoci
factor
exposur
comorbid
marker
inflamm
subset
patient
frequent
exacerb
identifi
postul
viral
exacerb
may
one
incit
factor
recurr
loss
control
cycl
exacerb
addit
evid
children
present
hospit
emerg
room
persist
rv
note
week
patient
associ
wors
peak
flow
present
like
contribut
sever
diseas
thu
impact
subsequ
control
contrast
chang
et
al
look
effect
document
viral
infect
cours
asthma
exacerb
subsequ
recoveri
viral
infect
predict
increas
sever
asthma
exacerb
clinic
defin
viral
ill
correl
featur
subsequ
outcom
particular
pediatr
asthma
qualiti
life
asthma
cough
diari
worsen
presenc
viral
infect
set
acut
asthma
exacerb
week
result
present
suggest
impact
viral
exacerb
subsequ
asthma
control
yet
entir
defin
research
need
area
abl
make
conclus
effect
asthma
control
viral
exacerb
airway
epithelium
act
physic
activ
immun
barrier
intern
environ
lung
extern
environ
contain
potenti
noxiou
gase
agent
pathogen
includ
virus
pathogenassoci
molecular
pattern
pamp
viral
bacteri
nucleic
acid
fungal
product
bacteri
endotoxin
lpss
interact
airway
epithelium
pamp
effici
recogn
divers
rang
innat
germlin
encod
receptor
cell
surfac
cytoplasm
aec
abl
elicit
strong
immun
respons
receptor
known
pattern
recognit
receptor
prr
respiratori
virus
hrv
rsv
coronavirus
influenza
viru
common
infecti
ill
airway
usual
selflimit
confin
respiratori
tract
presenc
rna
viru
infect
sens
via
prr
tlr
retino
acidinduc
gene
rigi
like
receptor
rlr
nucleotidebind
oligomer
domainlik
receptor
among
tlr
express
intracellular
endosom
bronchial
epithelium
cell
respond
presenc
doublestrand
rna
produc
replic
virus
trigger
signal
via
tirdomaincontain
adaptorinduc
trif
associ
tumor
necrosi
factor
tnf
receptorassoci
factor
lead
activ
ifn
regulatori
factor
transloc
nucleu
result
product
type
ifn
trif
also
interact
receptor
interact
protein
activ
product
inflammatori
cytokin
tlr
also
found
within
endosom
activ
singlestrand
rna
lead
activ
via
pathway
mainli
respons
detect
bacteri
endotoxin
howev
report
viral
protein
f
protein
rsv
detect
induc
type
ifn
proinflammatori
cytokin
via
activ
activ
protein
rlr
signal
play
major
role
detect
sever
picornavirus
influenza
viru
rsv
rig
recogn
rna
dsrna
viru
infect
melanoma
differentiationassoci
protein
detect
long
dsrna
kb
compon
viral
rna
recogn
rlr
receptor
initi
type
ifn
product
type
type
iii
ifn
crucial
role
control
viru
infect
airway
epithelium
type
ifn
act
type
ifn
receptor
via
pathway
activ
seri
ifnstimulatori
gene
produc
potent
antivir
protein
elimin
viru
infect
type
iii
ifn
ifn
ifn
also
known
also
elicit
antivir
fig
innat
adapt
immun
respons
respiratori
viru
infect
airway
normal
circumst
innat
immun
respons
viru
infect
trigger
infect
airway
epitheli
cell
recognit
viral
pathogen
associ
molecular
pattern
pamp
infect
epithelium
resid
immun
cell
cell
contain
variou
pathogen
recognit
receptor
prr
recognis
divers
rang
pamp
elicit
innat
adapt
immun
respons
elimin
viru
infect
viral
dsrna
recognis
rig
receptor
while
srna
mainli
sens
variou
dna
virus
recognis
cytoplasm
dna
sensor
cga
endosom
upon
recognit
downstream
signal
cascad
initi
produc
type
interferon
via
activ
induc
antivir
protein
inhibit
viral
replic
within
infect
cell
spread
neighbor
cell
inflammatori
cytokin
product
via
nfkb
activ
result
releas
recruit
activ
neutrophil
macrophag
infect
cell
releas
activ
nk
cell
produc
target
infect
cell
support
robust
environ
recruit
type
innat
lymphoid
cell
result
viral
clearanc
asthma
preexist
state
activ
airway
inflamm
case
activ
type
inflamm
presenc
increas
type
lymphocyt
cell
cell
promot
abnorm
state
follow
infect
asthmat
epithelium
heighten
releas
tslp
activ
cell
activ
cell
larg
produc
activ
inflammatori
cell
eosinophil
result
worsen
inflamm
airway
also
enhanc
ige
product
b
lymphocyt
may
impair
activ
innat
immun
cell
dendrit
cell
viru
infect
increas
express
type
cytokin
neg
regul
type
interferon
product
type
cytokin
also
enhanc
express
result
increas
viru
replic
respons
howev
cellular
receptor
distribut
differ
tissu
limit
besid
ifn
sever
cytokin
chemokin
produc
airway
epithelium
viru
infect
cytokineschemokin
possess
differ
role
innat
adapt
immun
cytokin
granulocyt
colonystimul
factor
gcsf
granulocyt
macrophagecsf
gmcsf
secret
upon
variou
respiratori
viru
infect
proinflammatori
cytokin
modul
lung
neutrophil
monocyt
cell
activ
increas
secret
result
excess
inflamm
damag
contrast
absenc
set
influenza
infect
result
increas
viral
replic
reduc
antivir
cell
activ
therefor
proper
balanc
lung
necessari
balanc
innat
adapt
immun
gcsf
modul
product
recruit
neutrophil
gmcsf
involv
expans
activ
pulmonari
dc
macrophag
also
gmcsf
shown
protect
role
influenza
viru
infect
potent
proinflammatori
cytokin
also
demonstr
antivir
activ
influenza
rsv
infect
chemokin
rant
also
induc
respiratori
viru
infect
mainli
recruit
neutrophil
lung
modul
activ
addit
variou
function
type
immun
cell
well
induc
variou
viru
infect
rsv
influenza
rv
airway
epithelium
produc
sever
cell
monocyt
neutrophil
eosinophil
epitheli
endotheli
fibroblast
respons
induc
rv
rsv
influenza
viru
etc
shown
protect
role
pathogen
infect
chemokin
induc
viral
infect
recruit
monocyt
cell
eosinophil
lung
induc
viral
clearanc
alreadi
discuss
defici
innat
ifn
respons
asthmat
epitheli
cell
releas
describ
though
case
studi
suggest
impair
correl
diseas
sever
promin
sever
less
control
asthma
howev
molecular
mechan
impair
innat
immun
respons
asthma
still
remain
obscur
propos
airway
inflammatori
environ
present
asthmat
airway
may
role
impair
innat
antivir
immun
treatment
recombin
epitheli
cell
shown
enhanc
rv
replic
suppress
type
iii
ifn
product
addit
shown
increas
intracellular
adhes
molecul
icam
express
epitheli
cell
result
increas
rv
infect
transform
growth
potent
mediat
airway
remodel
asthma
highli
express
asthmat
epithelium
express
suppress
airway
overexpress
enhanc
rv
infect
suppressor
cytokin
signal
soc
protein
neg
regul
cytokin
signal
intriguingli
appear
increas
asthma
moreov
rv
infect
cytokin
increas
asthmat
individu
result
dampen
ifn
product
continu
corticosteroid
treatment
also
demonstr
neg
effect
innat
antivir
effect
peripher
blood
mononuclear
cell
pretreat
budesonid
promot
rv
infect
reduc
type
ifn
product
addit
influenza
rv
demonstr
enhanc
viral
replic
aec
treat
glucocorticosteroid
exogen
ifn
adjuv
markedli
reduc
glucocorticosteroid
amplifi
viru
infect
follow
viral
infect
aec
releas
numer
immun
activ
mediat
reason
suggest
composit
epitheli
immun
respons
profound
impact
downstream
immun
pathway
regul
inflamm
ultim
diseas
sever
relev
infect
asthma
report
show
epithelium
express
mediat
drive
innat
type
antivir
immun
exampl
activ
group
innat
lymphoid
cell
releas
activ
natur
killer
nk
cell
recent
discov
innat
immun
cell
lymphoid
origin
lack
lineagespecif
marker
includ
b
cell
receptor
import
sourc
type
cytokin
express
array
cytokin
receptor
upon
activ
airway
epitheli
deriv
cytokin
thymic
stromal
lymphopoietin
produc
larg
amount
type
cytokin
type
cytokin
play
import
role
activ
mast
cell
eosinophil
basophil
induc
goblet
cell
hyperplasia
mucu
product
thu
directli
stimul
characterist
patholog
respons
asthma
rv
infect
aec
stimul
releas
activ
nfkb
pathway
drive
express
influenza
viru
also
induc
ahr
activ
via
secret
alveolar
macrophag
nkt
cell
stimul
product
accumul
eosinophil
lung
nk
cell
anoth
class
innat
immun
cell
aris
common
lymphoid
progenitor
play
import
role
defens
infecti
agent
includ
virus
follow
viral
infect
nk
cell
produc
larg
amount
support
immun
environ
lung
promot
viral
clearanc
play
critic
role
subsequ
develop
effector
respons
may
occur
indirectli
nk
cell
prime
dc
bidirect
crosstalk
releas
nk
cell
activ
dc
produc
turn
feed
back
nk
cell
amplifi
secret
howev
nk
cell
respons
impair
viral
infect
reduc
level
may
promot
type
immun
environ
lung
increas
inflamm
viral
replic
clinic
featur
asthma
interestingli
impair
nk
cell
respons
appear
strong
featur
acut
sever
rsv
bronchiol
previous
discuss
independ
predictor
recur
wheez
age
year
rv
infect
express
macrophag
dc
epitheli
cell
mediat
activ
expans
recruit
nk
cell
lung
elimin
viral
infect
cell
produc
granzym
impair
signal
affect
nk
cell
protect
featur
viru
henc
promot
asthma
influenza
viru
worsen
airway
inflamm
murin
asthma
model
strain
nk
cell
similarli
play
import
role
respons
influenza
increas
nk
cell
infiltr
within
first
day
infect
influenza
viru
import
nk
cell
receptor
bind
directli
influenza
viru
ha
protein
result
cell
activ
viru
clearanc
respiratori
viru
infect
especi
rsv
rv
major
caus
earli
childhood
wheez
ill
acut
event
infect
enough
trigger
recur
episod
wheez
particularli
recurr
rv
infect
like
influenc
perman
lung
develop
suscept
predispos
develop
asthma
later
life
establish
asthma
virus
remain
import
trigger
acut
exacerb
suscept
tend
either
preexist
poor
asthma
control
sever
underli
asthma
reason
suscept
respiratori
viru
infect
remain
unclear
clearli
close
relat
imbalanc
inflammatori
process
activ
asthma
involv
impair
type
iiii
ifn
product
coupl
excess
express
cytokin
activ
neutrophil
inflammatori
pathway
origin
thought
primarili
involv
control
viral
replic
grow
evid
type
ifn
also
import
neg
regul
inflamm
role
airway
epithelium
site
viral
replic
initi
inflammatori
pathway
caus
exacerb
well
establish
given
divers
virus
precipit
asthma
exacerb
antivir
vaccin
unlik
feasibl
treatment
option
result
research
focus
redress
asthmat
airway
epitheli
innat
immun
respons
viral
infect
